Vrishit Saraswat Publishes Breakthrough Study on Portal Vein Recanalization
Vrishit Saraswat, Chairperson and Head of Chandan Hospital, posted on LinkedIn:
”Excited to Share a Milestone in My Academic Journey
I’m truly delighted to share that our paper titled “Portal Vein Recanalization and TIPS in Pre-Transplant Patients for Chronic Portal Vein Thrombosis” has been accepted for publication in the Journal of the Japanese Society of Interventional Radiology (JSIR).
This achievement marks a meaningful step forward in exploring complex portal venous interventions in liver transplant candidates. It wouldn’t have been possible without the constant support, mentorship, and guidance of my incredible seniors and mentors – whose encouragement and insights guided me throughout every stage of this journey.
A huge thank you to my amazing co-authors, colleagues, and the interventional radiology team for their collaboration, hard work, and dedication. Every discussion, every case, and every late-night revision helped shape this research into what it is today.
Feeling immensely grateful and motivated to continue contributing to the ever-evolving field of Interventional Radiology and to pursue more meaningful collaborations ahead.”
Read the full article here.
Title: Recanalization of the Portal Vein and Transjugular Intrahepatic Portosystemic Shunt (PVR-TIPS) as an Aid for Live Donor Liver Transplantation in Cirrhotic Patients with Portal Vein Thrombosis
Authors: Vrishit Saraswat, Soumil Singhal, Anubhav Harish Khandelwal, Anurag Mehndiratta, Sonalika Jha, Rohit Khandelwal, Abhay Kapoor, Girendra Shankar Singh, Raghuveer Reddy, Heera Ram , Sanjay Saran Baijal

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?
-
Nov 15, 2026, 15:53Nicolas Schommer: The Seed and Soil Hypothesis of NET-Mediated Inflammation
-
Nov 15, 2026, 15:36Giovanni Merlino: Targeting LDL-C to Prevent Recurrent Stroke
-
Nov 15, 2026, 15:33Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice